- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04614688
Assessing the Impact of a Patient Education Platform to Augment the Informed Consent Process for Obstetrics and Gynecology Procedures
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
Informed consent is dependent on three criteria; the patient must be competent, relevant information including risks, benefits and alternatives must be clearly communicated, and the acceptance of treatment must be voluntary. The consent process usually occurs in the office setting through physician-led verbal communication. Despite satisfying the three criteria of informed consent, many patients leave the office with an inadequate understanding of the treatment they have consented to.
The purpose of this study is to use an interactive patient education pathway as an adjunct to the informed consent process for patients undergoing hysteroscopy. This will be done using a randomized controlled trial design.
Patients will be randomized to the control group (standard consent process) or the education group (standard consent process augmented by access to an interactive hysteroscopy teaching platform).
All patients will undergo the standard physician-led informed consent process. Patients from both groups will be asked to complete a post-informed consent questionnaire to assess their understanding of their upcoming procedure, preparedness for the procedure, and satisfaction with the informed consent process, be that through the traditional method or the interactive patient education portal.
Studietype
Registrering (Forventet)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
- Eldre voksen
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Women planning on undergoing a hysteroscopy procedure
Exclusion Criteria:
- Women NOT planning on undergoing a hysteroscopy procedure
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Helsetjenesteforskning
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Patient Education Group
Patients in this group will undergo the standard physician-led informed consent process and then be provided with an interactive patient education platform for hysteroscopy on a tablet available in the clinic for up to one hour of time.
After the patient has explored the patient education platform, they will be given a post-consent survey which will measure their understanding of the surgery, their readiness for the surgery, and their satisfaction with the consent process.
|
The patient education platform for hysteroscopy surgery is a website platform which has patient education materials regarding hysteroscopy procedures in the format of pictures, videos, and text.
Information on this platform includes anatomy of the surgery area, what to expect, reasons for the surgery, ways to prepare for the surgery, and recovering from the surgery.
|
Ingen inngripen: Standard Consent Group
Patients in this group will undergo the standard physician-led informed consent process only.
After they have consented to the surgery, they will be given a post-consent survey which will measure their understanding of the surgery, their readiness for the surgery, and their satisfaction with the consent process.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Patient Comprehension of their Upcoming Surgery
Tidsramme: After (but same day as) the patient has consented to surgery (control group) or after (but same day as) the patient has consented to surgery and explored the patient education platform (experimental group).
|
Patient comprehension of their upcoming surgery will be measured using a survey given after the patient has consented to their surgery (control group) and after viewing the patient education platform (experimental group).
The survey will ask the patient to name a benefit, risk, discomfort, and indication of the procedure, as well as a consequence to not having the procedure.
One point will be given for each correct answer.
Comprehension will be measured using a mean.
|
After (but same day as) the patient has consented to surgery (control group) or after (but same day as) the patient has consented to surgery and explored the patient education platform (experimental group).
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Patient Preparedness for their Upcoming Surgery
Tidsramme: After (but same day as) the patient has consented to surgery (control group) or after (but same day as) the patient has consented to surgery and explored the patient education platform (experimental group).
|
Patient preparedness for the upcoming surgery will be measured using a survey given after the patient has consented to their surgery (control group) and after viewing the patient education platform (experimental group).
Patients will be asked to indicate how prepared they feel on a 5-point Likert scale with 1 = Very Prepared and 5 = Very Unprepared.
|
After (but same day as) the patient has consented to surgery (control group) or after (but same day as) the patient has consented to surgery and explored the patient education platform (experimental group).
|
Patient Satisfaction with the Consent Process
Tidsramme: After (but same day as) the patient has consented to surgery (control group) or after (but same day as) the patient has consented to surgery and explored the patient education platform (experimental group).
|
Satisfaction with the consent process will be measured using a survey given after the patient has consented to their surgery (control group) and after viewing the patient education platform (experimental group).
Patients will be asked how much time they think was spent on the consent process (vs.
actual time spent, measured using a stop watch).
Difference between perceived time and actual time will be calculated.
Patients will also be asked if certain aspects of the consent process were covered by the doctor during the discussion (e.g.
"Was the procedure explained to you?", "Were the risks explained to you?").
Answer options will be "Yes/No".
Patients will be asked if they received enough information to make a sound decision and if their questions were answered to their satisfaction.
Answer options will be "Yes/No" Patient satisfaction will be determined using frequency counts.
|
After (but same day as) the patient has consented to surgery (control group) or after (but same day as) the patient has consented to surgery and explored the patient education platform (experimental group).
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Eliane Shore, MD, Unity Health Toronto
Studierekorddatoer
Studer hoveddatoer
Studiestart (Forventet)
Primær fullføring (Forventet)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- 20-215
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Patient Education Platform
-
University of MalayaFullførtTrykkskade | Begrensning, MobilitetMalaysia
-
Baylor College of MedicineAmerican Cancer Society, Inc.; Michael E. DeBakey VA Medical CenterFullført
-
University of BremenGerman Federal Ministry of Education and Research; Institute of Public... og andre samarbeidspartnereUkjentKreftrelatert tretthet
-
Nova Scotia Health AuthorityRekruttering
-
Universidad Autonoma de MadridFullført
-
Abramson Cancer Center at Penn MedicineRekruttering
-
Johns Hopkins UniversityApple Inc.; iHealthFullførtHjerteinfarkt | Koronararteriesykdom | Akutt koronarsyndrom | Akutt hjerteinfarktForente stater
-
Cogito Health IncNational Institute of Mental Health (NIMH); Brigham and Women's Hospital; Partners HealthCareFullførtBehavioral Health With Medical ComorbiditiesForente stater
-
Advocate Health CareTakeda; Lundbeck LLCFullførtMajor depressiv lidelseForente stater
-
Frederick Carrick, PhD, FACCNHealthTech Connex Inc.FullførtSunn | Traumatisk hjerneskadeForente stater